Envisagenics Email Format
Biotechnology ResearchNew York, United States11-50 Employees
Envisagenics is a biotechnology research company based in New York, New York. Founded in 2014 as a spinout of Cold Spring Harbor Laboratory, the company aims to reduce the complexity of biomedical data to accelerate the development of therapeutic solutions through RNA splicing analytics and artificial intelligence. The firm focuses on discovering RNA therapeutics and operates SpliceCore, a cloud-based platform that analyzes RNA sequencing data to identify splicing-related drug targets and biomarkers using AI. Envisagenics uses its in-silico RNA therapeutics discovery approach to identify splicing errors causative of diseases, identify the right drug-targets, and develop RNA therapeutics through collaborations with biopharma. In February 2025, Envisagenics announced the appointment of Sudhir Rao as Chief Business Officer.